Genentech files supplemental application for lymphoma drug (BizJournals)
Published by Yahoo! News Search Results for Food and Drug Admin March 31st, 2006 in Yahoo FDA News, Regulatory Affairs
Genentech Inc. and partner Biogen Idec Inc. said Thursday they turned in a supplemental use application for Rituxan, their lymphoma drug, to the Food and Drug Administration.